Long-term outcomes of combining prostate brachytherapy and metastasis-directed radiotherapy in newly diagnosed oligometastatic prostate cancer: A retrospective cohort study.
Hideyasu TsumuraHiromichi IshiyamaKen-Ichi TabataAkane SekiguchiShogo KawakamiTakefumi SatohMasashi KitanoMasatsugu IwamuraPublished in: The Prostate (2018)
This single-institutional study revealed the feasibility of combining prostate brachytherapy and MDRT for newly diagnosed oligometastatic prostate cancer. This combined approach has potential to prolong CRPC-free survival.